BG105207A - Pharmaceutical composition with antitumour activity on the basis of carboplatin - Google Patents

Pharmaceutical composition with antitumour activity on the basis of carboplatin

Info

Publication number
BG105207A
BG105207A BG105207A BG10520701A BG105207A BG 105207 A BG105207 A BG 105207A BG 105207 A BG105207 A BG 105207A BG 10520701 A BG10520701 A BG 10520701A BG 105207 A BG105207 A BG 105207A
Authority
BG
Bulgaria
Prior art keywords
carboplatin
pharmaceutical composition
antitumour activity
basis
weight
Prior art date
Application number
BG105207A
Other languages
Bulgarian (bg)
English (en)
Inventor
Vladimir Kysilka
Libuse LOUKALOVA
Miroslav MA.LECEK
Ronald Gust
Original Assignee
Pliva-Lachema, A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva-Lachema, A.S. filed Critical Pliva-Lachema, A.S.
Publication of BG105207A publication Critical patent/BG105207A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00Use of organic ingredients
    • C08K5/0091Complexes with metal-heteroatom-bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
BG105207A 1998-08-14 2001-01-31 Pharmaceutical composition with antitumour activity on the basis of carboplatin BG105207A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ19982588A CZ292170B6 (cs) 1998-08-14 1998-08-14 Farmaceutická kompozice s protinádorovým účinkem na bázi carboplatiny
PCT/CZ1999/000028 WO2000009097A2 (en) 1998-08-14 1999-08-10 Pharmaceutical composition with antitumor activity on the basis of carboplatin

Publications (1)

Publication Number Publication Date
BG105207A true BG105207A (en) 2001-07-31

Family

ID=5465233

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105207A BG105207A (en) 1998-08-14 2001-01-31 Pharmaceutical composition with antitumour activity on the basis of carboplatin

Country Status (17)

Country Link
US (1) US6589988B1 (de)
EP (1) EP1107750B1 (de)
AT (1) ATE281832T1 (de)
AU (1) AU5024599A (de)
BG (1) BG105207A (de)
CZ (1) CZ292170B6 (de)
DE (1) DE69921832T2 (de)
ES (1) ES2229737T3 (de)
HR (1) HRP20010110B1 (de)
HU (1) HUP0104304A3 (de)
NO (1) NO20010507D0 (de)
PL (1) PL346363A1 (de)
PT (1) PT1107750E (de)
RU (1) RU2188640C1 (de)
SK (1) SK284711B6 (de)
UA (1) UA73281C2 (de)
WO (1) WO2000009097A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999051246A1 (en) 1998-04-03 1999-10-14 Ajinomoto Co., Inc. Antitumor agents
AU2005329764B2 (en) * 2005-03-28 2010-08-12 Dabur Pharma Ltd. Stable pharmaceutical compositions of platinum (II) antitumour agents
KR101127159B1 (ko) * 2009-11-02 2012-03-20 한국생명공학연구원 식물병원성 그람음성 세균의 분비체계를 저해하는 카보프라틴 화합물을 유효성분으로 함유하는 식물병 방제제
CN112638363B (zh) * 2018-08-31 2025-01-24 太阳医药工业有限公司 卡铂的肠胃外剂型
US12427104B1 (en) 2025-04-01 2025-09-30 Ingenus Pharmaceuticals, Llc Injectable carboplatin formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS269719B1 (en) * 1986-12-29 1990-05-14 Kiss Frantisek Platinum cytostatic
JPH01146826A (ja) * 1987-12-03 1989-06-08 Nippon Kayaku Co Ltd 白金化合物の凍結乾燥製剤
NL8901433A (nl) * 1989-06-06 1991-01-02 Pharmachemie Bv Carboplatinpreparaat.
US5455270A (en) * 1993-08-11 1995-10-03 Bristol-Myers Squibb Co. Stabilized solutions of platinum(II) antitumor agents
DE69427595T2 (de) * 1994-02-07 2002-04-25 Pliva Pharmaceutical Industry Antitumormittel auf basis von carboplatin und herstellung desselben

Also Published As

Publication number Publication date
NO20010507L (no) 2001-01-30
EP1107750A2 (de) 2001-06-20
CZ258898A3 (cs) 2000-02-16
RU2188640C1 (ru) 2002-09-10
DE69921832D1 (de) 2004-12-16
ATE281832T1 (de) 2004-11-15
US6589988B1 (en) 2003-07-08
NO20010507D0 (no) 2001-01-30
HUP0104304A3 (en) 2004-04-28
CZ292170B6 (cs) 2003-08-13
ES2229737T3 (es) 2005-04-16
PL346363A1 (en) 2002-02-11
SK284711B6 (sk) 2005-09-08
HRP20010110B1 (en) 2005-10-31
EP1107750B1 (de) 2004-11-10
WO2000009097A3 (en) 2000-05-18
HRP20010110A2 (en) 2002-02-28
SK2092001A3 (en) 2001-07-10
DE69921832T2 (de) 2005-11-03
HUP0104304A2 (hu) 2002-03-28
PT1107750E (pt) 2005-02-28
WO2000009097A2 (en) 2000-02-24
UA73281C2 (en) 2005-07-15
AU5024599A (en) 2000-03-06

Similar Documents

Publication Publication Date Title
AU3518300A (en) Highly soluble and stable mineral supplements
KR880004819A (ko) 펩티드 제제
NZ264210A (en) Malonato platinum composition; stable injectable pharmaceutical compositions prepared using 1,1-cyclobutanedicarboxylic acid as stabiliser
BG105207A (en) Pharmaceutical composition with antitumour activity on the basis of carboplatin
US20070270591A1 (en) Iron (II) amino acid chelates with reducing agents attached thereto
Ragan The bioavailability of iron, lead and cadmium via gastrointestinal absorption: a review
JP4072668B2 (ja) 水質改良剤
RU2001104352A (ru) Фармацевтическая композиция с противоопухолевой активностью на основе карбоплатина
ES8700054A1 (es) Procedimiento de obtencion de germicidas a base de acidos clorhidrico y fosforico.
US20030175202A1 (en) Table salt, table sugar, and table vinegar formulations with nitrite scavengers
MXPA01007210A (es) Agente para el tratamiento de enfermedad de parkinson que comprende un agente que mejora la funcion del astrocito como ingrediente activo.
SG146690A1 (en) Infusion preparation containing (2r)-2-propyloctanoic acid as the active ingredient
Parchwani et al. Oxidative-inflammo mechanism of heavy metal toxicity
CA2534259A1 (en) Glycyrrhizin high-concentration preparation
EP0236822B1 (de) Stabile injizierbare Arzneiformulierung des 1,4-Dihydroxy-5,8-bis((2-(hydroxyäthylamino)-äthyl)amino)anthrachinondihydrochlorids
JP2006321776A (ja) アミノ酸を配位して成る金属錯体である抗菌防カビ剤とその二次製品
JP3824604B2 (ja) 抗酸化作用を有する亜鉛含有物
JPH06199693A (ja) 虚血性疾患改善治療剤
KR20140025369A (ko) 히알루론산 또는 히알루론산염을 포함하는 수용액
US20040214885A1 (en) Ferrous bisglycinate hydrochloride
GR20000100238A (el) Αναβραζοντα δισκια, που περιεχουν ως δραστικο συστατικο συμπλοκες ενωσεις σιδηρου, για την θεραπεια των σιδηροπενικων αναιμιων
JPH0475168B2 (de)
RU2000126015A (ru) Лекарственное средство для лечения и профилактики болезней, вызываемых недостаточностью селена в организме сельскохозяйственных животных
Lee Cadmium, mercury, and lead—the heavy metal gang
UA32629C2 (uk) Комплексний інфузійний препарат "сорбілакт"